a public good project by the
Synthesis
Company
of California

© 2026

Gabriella Lakos | doi.page

0 works0 citations0 h-index

Gabriella Lakos

Thermo Fisher Scientific (United Kingdom)(GB)Thermo Fisher Scientific (United States)(US)

Publications by Year

Research Areas

Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, Rheumatoid Arthritis Research and Therapies, Multiple Myeloma Research and Treatments, Platelet Disorders and Treatments

Most-Cited Works

→ Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients(2002)2,137 cited
→ 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends(2014)259 cited
→ Transglutaminase 2-/-mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells(2003)253 cited
→ Targeted Disruption of TGF-β/Smad3 Signaling Modulates Skin Fibrosis in a Mouse Model of Scleroderma(2004)212 cited
→ Disruption of transforming growth factor β signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator–activated receptor γ(2004)196 cited
→ Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis

(2009)

189 cited

→ International consensus guidelines on anticardiolipin and anti–β ₂ ‐glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies(2011)182 cited

→ ‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010(2011)178 cited

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.(2008)

Features associated with epilepsy in the antiphospholipid syndrome.(2004)